MNK Awaits D-Day, AMEH In Good Health, AXSM To Report ASCEND Data In Jan.

Today's Daily Dose brings you news about AbbVie's uterine fibroids trial results; Apollo Medical's third quarter financial results; Aldeyra Therapeutics' anticipated milestones; Axsome's progress in its ASCEND trial; BELLUS Health's near-term catalyst, and FDA panel's vote on Mallinckrodt's MNK-812.

from RTT - Biotech https://ift.tt/2QIUIbr
via IFTTT